Gurnet Point and Novo Holdings to acquire Paratek Pharmaceuticals for $462m

Oaktree Capital Management will provide $175 million in debt financing for this deal.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this